Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

Total and Gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies.

Diğer sürümleri göster (1)

PURPOSE: We measured concentrations of human glandular kallikrein 2 (hK2), total prostate specific antigen (tPSA), free PSA (fPSA) and percent fPSA to evaluate their relationship to total prostate gland volume, benign prostatic hyperplasia (BPH) volume, total prostate cancer (PCa) volume (CaVol) an...

Detaylı Bibliyografya
Asıl Yazarlar:	Haese, A, Graefen, M, Steuber, T, Becker, C, Noldus, J, Erbersdobler, A, Huland, E, Huland, H, Lilja, H
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2003

Benzer Materyaller

Total and gleason grade 4/5 cancer volumes are major contributors of human kallikrein 2, whereas free prostate specific antigen is largely contributed by benign gland volume in serum from patients with prostate cancer or benign prostatic biopsies
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
Yazar:: Steuber, T, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Human glandular kallikrein 2: a potential serum marker for predicting the organ confined versus non-organ confined growth of prostate cancer.
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

The role of human glandular kallikrein 2 for prediction of pathologically organ confined prostate cancer.
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2003)

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.
Yazar:: Steuber, T, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml.
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

[Isoforms of free prostate-specific antigen]
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Isoforms of free prostate-specific antigen
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Prostate-specific antigen and related isoforms in the diagnosis and management of prostate cancer.
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2004)

Prediction of tumor heterogeneity in localized prostate cancer.
Yazar:: Huland, H, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
Yazar:: Steuber, T, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Discrimination of prostate cancer from benign disease by selective measurements of serum subfractions of free PSA that are not internally cleaved at Lys145-Lys146
Yazar:: Nurmikko, P, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
Yazar:: Haese, A, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Enhanced discrimination of benign from malignant prostatic disease by selective measurements of cleaved forms of urokinase receptor in serum.
Yazar:: Piironen, T, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Anti-thrombin is expressed in the benign prostatic epithelium and in prostate cancer and is capable of forming complexes with prostate-specific antigen and human glandular kallikrein 2.
Yazar:: Cao, Y, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

Age and Prostatic Volume: The Prognosis for Benign Prostatic Hyperplasia
Yazar:: Dr. Afsheen Khan, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

Genetic Determinants of Metabolism and Benign Prostate Enlargement: Associations with Prostate Volume.
Yazar:: Ayush Giri, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Association of receptor expression with prostate volume in benign prostatic hyperplasia
Yazar:: Karli Sreenivasulu, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease.
Yazar:: Ylikoski, A, ve diğerleri
Baskı/Yayın Bilgisi: (2002)

The role of molecular forms of prostate-specific antigen (PSA or hK3) and of human glandular kallikrein 2 (hK2) in the diagnosis and monitoring of prostate cancer and in extra-prostatic disease.
Yazar:: Becker, C, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Relationship of age, prostate-specific antigen, and prostate volume in Indonesian men with benign prostatic hyperplasia
Yazar:: Ida Bagus O.W. Putra, ve diğerleri
Baskı/Yayın Bilgisi: (2016-06-01)

Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer
Yazar:: R.S. Pompe, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
Yazar:: Steuber, T, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

A study on survivin expression in prostate cancer and benign prostatic hyperplasia; and its association with pre-operative serum prostate specific antigen and gleason score in prostate cancer
Yazar:: Hadi, Normila Abdul
Baskı/Yayın Bilgisi: (2016)

Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
Yazar:: Becker, C, ve diğerleri
Baskı/Yayın Bilgisi: (2000)

Correlation between prostate volume and prostate-specific antigen in patients diagnosed with benign prostatic hyperplasia
Yazar:: Udoh EA, ve diğerleri
Baskı/Yayın Bilgisi: (2020-12-01)

RELATION OF TOTAL CHOLESTEROL TO PROSTATE VOLUME AND INTRAVESICAL PROSTATIC PROTRUSION IN BENIGN PROSTATIC HYPERPLASIA PATIENTS
Yazar:: Made Devi Desyana Arisandi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

Clinical value of prostate segmentation and volume determination on MRI in benign prostatic hyperplasia
Yazar:: Brian Garvey, ve diğerleri
Baskı/Yayın Bilgisi: (2014-05-01)

The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature
Yazar:: Dominique Thomas, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Study of CD117 Expression and Its Relationship with Benign Prostatic Hyperplasia and Gleason Score in Prostatic Adenocarcinoma
Yazar:: Mehdi Rahmanpour, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

Serum prostate specific antigen is a good indicator of prostatic volume in men with benign prostatic hyperplasia
Yazar:: Ebenezer Abotsi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
Yazar:: Steuber, T, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
Yazar:: Muhammed M. Qalawena, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

EMBOLIZATION AND CHEMOEMBOLIZATION PROSTATIC ARTERIES OF BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
Yazar:: N. B. Tabynbaev, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

Relationship of Prostate-Specific Antigen (PSA) and Prostate Volume in Patients with Biopsy Proven Benign Prostatic Hyperplasia (BPH)
Yazar:: Aulia Nur Fadila, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Renin-angiotensin and kallikrein-kinin systems: a significance in the benign prostatic hyperplasia pathogenesis
Yazar:: M. B. Chibichyan, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

Benign Prostate Hyperplasia: Average Volume in Southwestern Nigerians and Correlation with Anthropometrics
Yazar:: T A Badmus, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Benign prostate hyperplasia: average volume in southwestern Nigerians and correlation with anthropometrics
Yazar:: T A Badmus, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Circulating biomarkers for prostate cancer.
Yazar:: Steuber, T, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

A MICROBIAL CONTAMINATION OF PROSTATIC TISSUE IN BENIGN PROSTATIC HYPERPLASIA AND PROSTATE CANCER
Yazar:: Y. L. Naboka, ve diğerleri
Baskı/Yayın Bilgisi: (2013-03-01)